Format

Send to

Choose Destination
J Antibiot (Tokyo). 1992 Nov;45(11):1746-52.

Epoxomicin, a new antitumor agent of microbial origin.

Author information

1
Bristol-Myers Squibb Research Institute, Tokyo, Japan.

Abstract

An actinomycete strain No. Q996-17 produced a novel compound, epoxomicin, which exhibited in vivo antitumor activity against B16 melanoma. Structural studies indicated that it is a new member of the epoxy-beta-aminoketone group, and is closely related to eponemycin.

PMID:
1468981
DOI:
10.7164/antibiotics.45.1746
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for J-STAGE, Japan Science and Technology Information Aggregator, Electronic
Loading ...
Support Center